Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of “Hold” by Analysts

Health Catalyst, Inc. (NASDAQ:HCAT) has received an average rating of “Hold” from the thirteen brokerages that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and four have given a buy recommendation to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $2.7955.

A number of research analysts have weighed in on HCAT shares. Canaccord Genuity Group lowered their target price on Health Catalyst from $5.00 to $2.00 and set a “buy” rating on the stock in a report on Friday, March 13th. Citigroup lowered their price objective on Health Catalyst from $2.75 to $1.75 and set a “neutral” rating on the stock in a research report on Friday, March 13th. Cantor Fitzgerald lowered their price objective on Health Catalyst from $4.00 to $3.00 and set a “neutral” rating on the stock in a research report on Friday, March 13th. Raymond James Financial set a $3.00 price objective on Health Catalyst in a research report on Friday, March 13th. Finally, Stephens lowered their price objective on Health Catalyst from $3.50 to $2.00 and set an “equal weight” rating on the stock in a research report on Friday, March 13th.

Health Catalyst Price Performance

HCAT stock opened at $1.52 on Monday. Health Catalyst has a fifty-two week low of $0.96 and a fifty-two week high of $4.74. The business’s 50-day moving average is $1.37 and its two-hundred day moving average is $2.08. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.89 and a current ratio of 1.89. The company has a market cap of $111.86 million, a price-to-earnings ratio of -0.60 and a beta of 1.63.

Health Catalyst (NASDAQ:HCAT) last posted its earnings results on Thursday, March 12th. The company reported $0.08 earnings per share for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.02). Health Catalyst had a negative net margin of 57.20% and a negative return on equity of 4.30%. The firm had revenue of $74.68 million during the quarter, compared to the consensus estimate of $73.99 million. As a group, analysts forecast that Health Catalyst will post -0.28 earnings per share for the current year.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. First Light Asset Management LLC lifted its position in shares of Health Catalyst by 9.9% during the 3rd quarter. First Light Asset Management LLC now owns 13,436,220 shares of the company’s stock valued at $38,293,000 after buying an additional 1,206,039 shares in the last quarter. Vanguard Group Inc. raised its stake in Health Catalyst by 2.9% during the 3rd quarter. Vanguard Group Inc. now owns 4,295,691 shares of the company’s stock valued at $12,243,000 after purchasing an additional 119,117 shares during the period. Whetstone Capital Advisors LLC raised its stake in Health Catalyst by 0.5% during the 4th quarter. Whetstone Capital Advisors LLC now owns 3,750,377 shares of the company’s stock valued at $8,963,000 after purchasing an additional 19,027 shares during the period. Nepsis Inc. raised its stake in Health Catalyst by 26.6% during the 4th quarter. Nepsis Inc. now owns 1,915,794 shares of the company’s stock valued at $4,579,000 after purchasing an additional 402,762 shares during the period. Finally, Geode Capital Management LLC boosted its stake in Health Catalyst by 11.4% in the 2nd quarter. Geode Capital Management LLC now owns 1,662,455 shares of the company’s stock worth $6,269,000 after purchasing an additional 169,580 shares during the period. 85.00% of the stock is owned by hedge funds and other institutional investors.

Health Catalyst Company Profile

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.